Dermex Dermex II
Executive Summary
Dermatologic committee will discuss NDA 20-996 for Dermex Pharmaceuticals' zinc oxinate ointment for treatment of actinic keratosis, basal cell carcinoma and squamous cell carcinoma at its June 29 meeting. The committee will also discuss Schering-Plough's NDA for Lotrisone the same day (1"The Pink Sheet" May 29, In Brief). The meeting will be at the Holiday Inn in Bethesda, Md. at 10 a.m. The committee review of J&J's miconazole nitrate will be on June 30 at 8:30 a.m